Spiro-piperidine Inhibitors


Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds that have been identified as being capable of interaction with the M2 protein.

Download PDF
Document Preview
Document History
  • Publication: Oct 15, 2013
  • Application: Aug 21, 2009
    US US 54550109 A
  • Priority: Aug 21, 2009
    US US 54550109 A
  • Priority: Sep 16, 2008
    US US 9747408 P

Download Citation

Sign in to the Lens